| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |